CCCC C4 Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$2,95
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,7352-Wochen-Tief
$5,1752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$363M
P/E (TTM)
-3.2
EPS (TTM)
$-0.91
Umsatz (TTM)
$35M
Ihre Abzeichen
52W-Spanne
$2–$5
Analystenbewertung
BUY
Kursziel
$13
P/E
-3.2
ROE
-48.1%
Nettogewinnmarge
-289.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CCCC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.95
Marktkapitalisierung (MRQ)
$363M
P/E (TTM)
-3.2
EPS (TTM)
$-0.91
Umsatz (TTM)
$35M
ROE (TTM)
-48.1%
52W-Spanne
$2–$5
CCCC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über C4 Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter104
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$36M2021-12-31 → 2025-12-31
EPS$-1.272021-12-31 → 2025-12-31
Freier Cashflow$-99M2020-12-31 → 2025-12-31
Nettogewinnmarge-289.4%2022-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CCCC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -3.25-Jahres-Durchschnitt ≈-5.2 | ≈-5.2 | · | · | |
| P/S (TTM) | 10.35-Jahres-Durchschnitt ≈14.5 | ≈14.5 | 16.4 | Fairer Wert | |
| K/B (MRQ) | 1.55-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 2.6 | Fairer Wert | |
| Kurs / FCF (TTM) | -4.25-Jahres-Durchschnitt ≈-5.9 | ≈-5.9 | · | · | |
| Kurs / Cashflow (TTM) | -4.35-Jahres-Durchschnitt ≈-5.9 | ≈-5.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.15-Jahres-Durchschnitt ≈1.7 | ≈1.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CCCC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -319.0%5-Jahres-Durchschnitt ≈-435.8% | ≈-435.8% | -164.6% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -320.5%5-Jahres-Durchschnitt ≈-435.8% | ≈-435.8% | -164.6% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -291.7%5-Jahres-Durchschnitt ≈-406.5% | ≈-406.5% | -135.6% | Schwach | |
| Nettogewinnmarge (TTM) | -289.4%5-Jahres-Durchschnitt ≈-409.6% | ≈-409.6% | -245.9% | Unterdurchschnittlich | |
| ROA (TTM) | -30.9%5-Jahres-Durchschnitt ≈-27.5% | ≈-27.5% | -27.3% | Im Einklang | |
| ROE (TTM) | -48.1%5-Jahres-Durchschnitt ≈-43.1% | ≈-43.1% | -21.3% | Unterdurchschnittlich | |
| ROIC | -45.0%5-Jahres-Durchschnitt ≈-52.5% | ≈-52.5% | -45.8% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CCCC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.45-Jahres-Durchschnitt ≈6.5 | ≈6.5 | 5.4 | Im Einklang | |
| Quick Ratio | 2.35-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 2.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CCCC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 1.0%5-Jahres-Durchschnitt ≈1.8% | ≈1.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CCCC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.2 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 13.15-Jahres-Durchschnitt ≈7.4 | ≈7.4 | 7.9 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$345.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
21.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.18 | $-0.23 | 22.0% |
| 31. März 2026 | $-0.20 | $-0.38 | 47.3% | |
| 31. Dezember 2025 | $-0.18 | $-0.31 | 41.9% | |
| 30. September 2025 | $-0.44 | $-0.41 | -6.2% | |
| 30. Juni 2025 | $-0.37 | $-0.39 | 5.5% | |
| 31. März 2025 | $-0.37 | $-0.46 | 19.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $36M | $36M | $21M | $31M | $46M | |
| R&D Expense | $104M | $111M | $118M | $118M | $95M | |
| SG&A Expense | $36M | $42M | $42M | $43M | $33M | |
| Operating Expenses | $151M | $155M | $160M | $161M | $128M | |
| Operating Income | $-115M | $-120M | $-139M | $-130M | $-82M | |
| Other Non-op | $10M | $14M | $8M | $1M | $-2M | |
| Pretax Income | $-105M | $-105M | $-131M | $-128M | $-84M | |
| Income Tax | $121.0K | $131.0K | $1M | $0 | $0 | |
| Net Income | $-105M | $-105M | $-132M | $-128M | $-84M | |
| EPS (Basic) | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 | |
| EPS (Diluted) | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 | |
| Shares (Basic) | 82,894,459 | 69,372,993 | 49,640,505 | 48,861,665 | 46,041,733 | |
| Shares (Diluted) | 82,894,459 | 69,372,993 | 49,640,505 | 48,861,665 | 46,041,733 | |
| EBITDA | $-115M | $-120M | $-139M | $-130M | $-82M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $55M | $127M | $30M | $76M | |
| Short-term Investments | · | · | · | · | $233M | |
| Receivables | $2M | $3M | $12M | $1M | $6M | |
| Prepaid Expense | $7M | $10M | $6M | $10M | $11M | |
| Current Assets | $258M | $258M | $271M | $288M | $326M | |
| PP&E (Net) | $5M | $6M | $7M | $7M | $3M | |
| PP&E (Gross) | $16M | $15M | $15M | $16M | $10M | |
| Accum. Depreciation | $11M | $9M | $8M | $8M | $7M | |
| Other Non-current Assets | $4M | $3M | $3M | $2M | $544.0K | |
| Total Assets | $359M | $350M | $376M | $431M | $507M | |
| Accounts Payable | $858.0K | $1M | $1M | $1M | $5M | |
| Current Liabilities | $33M | $45M | $43M | $45M | $51M | |
| Capital Leases | $54M | $60M | $66M | $71M | $31M | |
| Total Liabilities | $102M | $134M | $130M | $142M | $117M | |
| Long-term Debt | · | · | $0 | $11M | $11M | |
| Total Debt | · | · | $0 | $11M | $11M | |
| Common Stock | $9.0K | $7.0K | $6.0K | $5.0K | $5.0K | |
| Retained Earnings | $-739M | $-634M | $-528M | $-396M | $-268M | |
| AOCI | $50.0K | $53.0K | $-127.0K | $-4M | $-775.0K | |
| Stockholders' Equity | $257M | $216M | $246M | $289M | $390M | |
| Liabilities + Equity | $359M | $350M | $376M | $431M | $507M | |
| Shares Outstanding | 96,914,418 | 70,625,899 | 60,467,188 | 48,966,216 | 48,688,875 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $19M | $30M | $27M | $30M | $22M | |
| Restructuring | $0 | $2M | $0 | · | · | |
| Operating Cash Flow | $-99M | $-65M | $-107M | $-106M | $-87M | |
| CapEx | $607.0K | $180.0K | $2M | $5M | $1M | |
| Investing Cash Flow | $-9M | $-51M | $158M | $58M | $-189M | |
| Stock Issued | · | · | $58M | $0 | · | |
| Stock Repurchased | $193.0K | $194.0K | $110.0K | $0 | · | |
| Net Stock Activity | $-193.0K | $-194.0K | $58M | · | · | |
| Financing Cash Flow | $126M | $45M | $45M | $1M | $171M | |
| Net Change in Cash | $19M | $-71M | $97M | $-46M | $-105M | |
| Taxes Paid | $131.0K | $76.0K | · | · | · | |
| Free Cash Flow | $-99M | $-65M | $-109M | $-111M | $-88M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -320.5% | -336.1% | -669.8% | -416.6% | · | |
| Net Margin | -292.1% | -296.0% | -638.3% | -412.2% | · | |
| Pretax Margin | -291.7% | -295.6% | -632.2% | · | · | |
| EBITDA Margin | -320.5% | -336.1% | -669.8% | -416.6% | · | |
| ROA | -29.6% | -29.0% | -32.8% | -27.3% | -18.5% | |
| ROE | -48.8% | -45.9% | -57.3% | -42.2% | -21.3% | |
| ROIC | -45.0% | -55.5% | -57.0% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 5.7 | 6.3 | 6.5 | 6.4 | |
| Quick Ratio | 2.3 | 1.3 | 3.2 | 0.7 | 6.1 | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | 13.1 | 4.8 | 3.1 | 8.7 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $2.65 | $3.06 | $4.07 | $5.91 | $8.00 | |
| Revenue / Share | $0.43 | $0.51 | $0.42 | $0.64 | · | |
| Cash Flow / Share | $-1.19 | $-0.94 | $-2.15 | $-2.17 | · | |
| Cash / Share | $0.77 | $0.79 | $2.09 | $0.61 | $1.56 | |
| EPS (TTM) | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 1.0% | 71.4% | -33.2% | -32.1% | · | |
| Revenue CAGR 3Y | 5.0% | -8.1% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $36M | $36M | $21M | $31M | $46M | |
| Net Income TTM | $-105M | $-105M | $-132M | $-128M | $-84M | |
| Market Cap | $185M | $254M | $342M | $289M | $1.57B | |
| Enterprise Value | · | · | $215M | $271M | $1.27B | |
| P/E | -1.5 | -2.4 | -2.1 | -2.3 | -17.7 | |
| P/S | 5.1 | 7.1 | 16.5 | 9.3 | 34.2 | |
| P/B | 0.7 | 1.2 | 1.4 | 1.0 | 4.0 | |
| P / Tangible Book | 0.7 | 1.2 | 1.4 | 1.0 | 4.0 | |
| P / Cash Flow | -1.9 | -3.9 | -3.2 | -2.7 | -18.0 | |
| P / FCF | -1.9 | -3.9 | -3.1 | -2.6 | -17.8 | |
| EV / EBITDA | · | · | -1.5 | -2.1 | -15.5 | |
| EV / FCF | · | · | -2.0 | -2.4 | -14.4 | |
| EV / Revenue | · | · | 10.4 | 8.7 | 27.7 | |
| Earnings Yield | -66.5% | -42.2% | -47.3% | -44.4% | -5.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $6M | $11M | $11M | $6M | $7M | $5M | $15M | $12M | $3M | $3M | $11M | $3M | $4M | $3M | $7M | |
| R&D Expense | $24M | $25M | $25M | $26M | $26M | $27M | $33M | $32M | $24M | $23M | $30M | $28M | $30M | $29M | $31M | $30M | |
| SG&A Expense | $9M | $9M | $9M | $9M | $9M | $9M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $11M | $10M | $10M | |
| Operating Expenses | $33M | $34M | $34M | $46M | $35M | $36M | $43M | $44M | $33M | $35M | $41M | $39M | $40M | $40M | $41M | $39M | |
| Operating Income | $-26M | $-28M | $-23M | $-34M | $-29M | $-29M | $-38M | $-28M | $-21M | $-32M | $-37M | $-28M | $-38M | $-36M | $-38M | $-32M | |
| Other Non-op | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $3M | $2M | $2M | $1M | $1M | $530.0K | |
| Pretax Income | · | · | $-20M | $-32M | $-26M | $-26M | $-34M | $-25M | $-18M | $-28M | $-34M | $-26M | $-36M | $-35M | $-37M | $-32M | |
| Income Tax | $0 | $0 | $121.0K | $0 | $0 | $0 | $131.0K | $0 | $0 | $0 | $277.0K | $1M | $0 | $0 | $0 | $0 | |
| Net Income | $-24M | $-25M | $-20M | $-32M | $-26M | $-26M | $-35M | $-25M | $-18M | $-28M | $-35M | $-27M | $-36M | $-35M | $-37M | $-32M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.09 | $-0.44 | $-0.37 | $-0.37 | $-0.50 | $-0.35 | $-0.26 | $-0.41 | $-0.68 | $-0.55 | $-0.73 | $-0.71 | $-0.76 | $-0.65 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.09 | $-0.44 | $-0.37 | $-0.37 | $-0.50 | $-0.35 | $-0.26 | $-0.41 | $-0.68 | $-0.55 | $-0.73 | $-0.71 | $-0.76 | $-0.65 | |
| Shares (Basic) | 130,696,742 | 126,074,555 | · | 72,563,311 | 71,005,743 | 70,833,044 | · | 69,627,190 | 68,810,259 | 68,432,168 | · | 49,212,126 | 49,063,631 | 49,032,319 | · | 48,921,928 | |
| Shares (Diluted) | 130,696,742 | 126,074,555 | · | 72,563,311 | 71,005,743 | 70,833,044 | · | 69,627,190 | 68,810,259 | 68,432,168 | · | 49,212,126 | 49,063,631 | 49,032,319 | · | 48,921,928 | |
| EBITDA | $-26M | $-27M | · | $-34M | $-29M | $-29M | · | $-28M | $-21M | $-32M | · | $-28M | $-38M | $-36M | · | $-32M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $61M | $75M | $59M | $78M | $51M | $55M | $60M | $73M | $90M | $127M | $61M | $45M | $49M | $30M | $50M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $264M | |
| Receivables | $1M | $3M | $2M | $7M | $2M | $8M | $3M | $10M | $1M | $14M | $12M | $500.0K | $1M | $528.0K | $1M | $1M | |
| Prepaid Expense | $8M | $7M | $7M | $8M | $8M | $9M | $10M | $7M | $11M | $8M | $6M | $7M | $6M | $8M | $10M | $10M | |
| Current Assets | $263M | $245M | $258M | $207M | $225M | $233M | $258M | $273M | $276M | $280M | $271M | $224M | $274M | $278M | $288M | $325M | |
| PP&E (Net) | $4M | $4M | $5M | $5M | $6M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | $8M | $7M | $7M | |
| PP&E (Gross) | $16M | $16M | $16M | $16M | $16M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $16M | $16M | $15M | |
| Accum. Depreciation | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $9M | $8M | $8M | |
| Other Non-current Assets | $4M | $4M | $4M | $211.0K | $178.0K | $3M | $3M | $5M | $3M | $5M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Total Assets | $359M | $329M | $359M | $265M | $297M | $320M | $350M | $376M | $381M | $398M | $376M | $333M | $375M | $396M | $431M | $461M | |
| Accounts Payable | $1M | $773.0K | $858.0K | $1M | $2M | $683.0K | $1M | $2M | $913.0K | $2M | $1M | $1M | $2M | $1M | $1M | $2M | |
| Current Liabilities | $48M | $27M | $33M | $36M | $44M | $41M | $45M | $43M | $54M | $55M | $43M | $30M | $48M | $39M | $45M | $45M | |
| Capital Leases | $50M | $52M | $54M | $55M | $57M | $58M | $60M | $61M | $63M | $64M | $66M | $67M | $68M | $70M | $71M | $72M | |
| Total Liabilities | $112M | $95M | $102M | $111M | $122M | $124M | $134M | $133M | $134M | $140M | $130M | $117M | $141M | $134M | $142M | $143M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $10M | $12M | $11M | $11M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $11M | · | $11M | |
| Common Stock | $12.0K | $10.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-787M | $-764M | $-739M | $-718M | $-686M | $-660M | $-634M | $-599M | $-574M | $-557M | $-528M | $-494M | $-467M | $-431M | $-396M | $-359M | |
| AOCI | $-444.0K | $-322.0K | $50.0K | $87.0K | $-30.0K | $43.0K | $53.0K | $455.0K | $-440.0K | $-380.0K | $-127.0K | $-904.0K | $-2M | $-2M | $-4M | $-5M | |
| Stockholders' Equity | $247M | $234M | $257M | $154M | $174M | $195M | $216M | $243M | $247M | $258M | $246M | $216M | $234M | $262M | $289M | $318M | |
| Liabilities + Equity | $359M | $329M | $359M | $265M | $297M | $320M | $350M | $376M | $381M | $398M | $376M | $333M | $375M | $396M | $431M | $461M | |
| Shares Outstanding | 122,905,756 | 104,036,350 | 96,914,418 | 74,174,515 | 71,007,083 | 70,989,661 | 70,625,899 | 70,562,901 | 68,815,642 | 68,778,591 | 60,467,188 | 49,259,870 | 49,065,098 | 49,052,509 | 48,966,216 | 48,951,283 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $292.0K | $404.0K | · | $460.0K | $615.0K | $456.0K | · | $442.0K | $448.0K | $448.0K | · | $447.0K | · | · | · | · | |
| Stock-based Comp | $3M | $3M | $4M | $5M | $5M | $6M | $8M | $9M | $6M | $6M | $6M | $8M | $6M | $6M | $7M | $6M | |
| Other Non-cash | · | $-8M | · | · | · | $-13M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-30M | $-22M | $-31M | $-12M | $-33M | $-18M | $-24M | $-5M | $-18M | $-24M | $-31M | $-19M | $-33M | $-29M | $-28M | |
| CapEx | $37.0K | $64.0K | $11.0K | $411.0K | $185.0K | $0 | $-4.0K | $-13.0K | $197.0K | $0 | $157.0K | $600.0K | $362.0K | $589.0K | $1M | $3M | |
| Investing Cash Flow | $-15M | $16M | $-81M | $4M | $39M | $29M | $14M | $162.0K | $-12M | $-53M | $32M | $58M | $15M | $54M | $9M | $20M | |
| Stock Repurchased | $0 | $200.0K | $14.0K | $24.0K | $0 | $155.0K | $0 | $85.0K | $0 | $109.0K | $0 | $16.0K | $0 | $94.0K | $0 | $0 | |
| Net Stock Activity | · | $-200.0K | · | · | · | $-155.0K | · | · | · | $-109.0K | · | · | · | $-94.0K | · | · | |
| Financing Cash Flow | $34M | $462.0K | $119M | $8M | $0 | $-46.0K | $112.0K | $11M | $135.0K | $35M | $58M | $-11M | $-746.0K | $-684.0K | $47.0K | $361.0K | |
| Net Change in Cash | $17M | $-13M | $16M | $-19M | $27M | $-4M | $-4M | $-13M | $-17M | $-37M | $66M | $16M | $-5M | $20M | $-20M | $-8M | |
| Free Cash Flow | · | $-30M | · | · | · | · | · | · | · | $-18M | · | · | · | $-34M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -397.9% | -451.6% | · | -306.4% | -441.0% | -402.9% | · | -183.9% | -178.6% | -1060.2% | · | -251.2% | -1410.2% | -963.8% | · | -481.0% | |
| Net Margin | -355.9% | -408.5% | · | -286.4% | -402.6% | -363.7% | · | -160.6% | -147.6% | -933.2% | · | -244.2% | -1348.4% | -925.2% | · | -473.2% | |
| Pretax Margin | · | · | · | -286.4% | -402.6% | -363.7% | · | -160.6% | -147.6% | -933.2% | · | -235.1% | · | · | · | · | |
| EBITDA Margin | -397.9% | -445.1% | · | -306.4% | -441.0% | -396.6% | · | -183.9% | -178.6% | -1060.2% | · | -251.2% | -1410.2% | -963.8% | · | -481.0% | |
| ROA | -7.2% | -7.8% | · | -8.8% | -6.6% | -7.6% | · | · | · | -7.8% | · | · | · | -7.6% | · | -6.6% | |
| ROE | -11.2% | -11.7% | · | -13.6% | -10.0% | -12.0% | · | · | · | -12.0% | · | · | · | -11.1% | · | -8.9% | |
| ROIC | · | · | · | -22.3% | · | -14.9% | · | · | · | -12.5% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 9.0 | · | 5.8 | 5.1 | 5.7 | · | · | · | 5.1 | · | · | · | 7.1 | · | 7.2 | |
| Quick Ratio | 1.7 | 2.4 | · | 1.8 | 1.8 | 1.5 | · | · | · | 1.9 | · | · | · | 1.3 | · | 7.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | 3.8 | 1.1 | · | 2.8 | 3.3 | 0.8 | · | · | · | 0.4 | · | · | · | 3.3 | · | 2.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.01 | $2.25 | · | $2.08 | $2.45 | $2.75 | · | · | · | $3.76 | · | · | · | $5.35 | · | $6.50 | |
| Revenue / Share | $0.05 | $0.05 | · | $0.15 | $0.09 | $0.10 | · | $0.22 | $0.17 | $0.04 | · | $0.23 | $0.05 | $0.08 | · | $0.14 | |
| Cash Flow / Share | · | $-0.24 | · | · | · | $-0.47 | · | · | · | $-0.26 | · | · | · | $-0.68 | · | · | |
| Cash / Share | $0.64 | $0.59 | · | $0.79 | $1.10 | $0.72 | · | · | · | $1.30 | · | · | · | $1.01 | · | $1.01 | |
| EPS (TTM) | $-0.91 | $-1.10 | · | $-1.68 | $-1.59 | $-1.48 | · | $-1.70 | $-1.90 | $-2.37 | · | $-2.75 | $-2.85 | $-2.68 | · | $-2.17 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $35M | $35M | · | $30M | $34M | $40M | · | $34M | $29M | $20M | · | $20M | $16M | $27M | · | $48M | |
| Net Income TTM | $-101M | $-104M | · | $-119M | $-112M | $-103M | · | $-105M | $-108M | $-126M | · | $-135M | $-140M | $-131M | · | $-107M | |
| Market Cap | $574M | $274M | · | $165M | $102M | $114M | · | · | · | $562M | · | · | · | $154M | · | $429M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $115M | · | $127M | |
| P/E | -5.1 | -2.4 | · | -1.3 | -0.9 | -1.1 | · | -3.4 | -2.4 | -3.4 | · | -0.7 | -1.0 | -1.2 | · | -4.0 | |
| P/S | 16.4 | 7.8 | · | 5.5 | 3.0 | 2.9 | · | · | 10.8 | 28.0 | · | 4.5 | 8.4 | 5.7 | · | 8.9 | |
| P/B | 2.3 | 1.2 | · | 1.1 | 0.6 | 0.6 | · | · | · | 2.2 | · | · | · | 0.6 | · | 1.3 | |
| P / Tangible Book | 2.3 | 1.2 | · | 1.1 | 0.6 | 0.6 | · | · | · | 2.2 | · | · | · | 0.6 | · | 1.3 | |
| P / Cash Flow | · | -9.1 | · | · | · | -3.4 | · | · | · | -31.0 | · | · | · | -4.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1.5 | 6.3 | 4.2 | · | 2.6 | |
| Earnings Yield | -19.5% | -41.8% | · | -75.7% | -111.2% | -92.5% | · | -29.8% | -41.1% | -29.0% | · | -147.8% | -103.6% | -85.4% | · | -24.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $36M | $36M | $21M | $31M | $46M |
| Betriebsgewinnmarge % | -320.5% | -336.1% | -669.8% | -416.6% | · |
| Nettoergebnis | $-105M | $-105M | $-132M | $-128M | $-84M |
| Verwässerte EPS | $-1.27 | $-1.52 | $-2.67 | $-2.62 | $-1.82 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | 0.0 | 0.0 |
| Liquiditätsgrad | 7.8 | 5.7 | 6.3 | 6.5 | 6.4 |
| Quick Ratio | 2.3 | 1.3 | 3.2 | 0.7 | 6.1 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-99M | $-65M | $-109M | $-111M | $-88M |
Institutionelle Eigentümer (13F) 162 Einreicher · $544.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
162
Gehaltener Wert
$544.7M
Neue Positionen
55
Geschlossene Positionen
25
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 55 (+18 vs. Vorquartal) | 25 (+16 vs. Vorquartal) | 54 (+11 vs. Vorquartal) | 30 (+1 vs. Vorquartal) | +30.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MORGAN STANLEY | $41.410.468 | 8.867.338 | 7,60% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $37.360.000 | 8.000.000 | 6,86% | Aktien |
| BlackRock, Inc. | $36.877.672 | 7.896.718 | 6,77% | Aktien |
| Lynx1 Capital Management LP | $34.215.647 | 7.326.691 | 6,28% | Aktien |
| Squadron Capital Management LLC | $33.624.000 | 7.200.000 | 6,17% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $33.492.820 | 7.171.910 | 6,15% | Aktien |
| JPMORGAN CHASE & CO | $20.651.295 | 4.747.424 | 3,79% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.630.804 | 4.417.731 | 3,79% | Aktien |
| CITADEL ADVISORS LLC | $19.555.999 | 4.187.580 | 3,59% | Aktien |
| GOLDMAN SACHS GROUP INC | $16.489.728 | 3.530.991 | 3,03% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $16.203.532 | 3.469.707 | 2,97% | Aktien |
| Soleus Capital Management, L.P. | $15.775.171 | 3.377.981 | 2,90% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $14.159.720 | 3.032.060 | 2,60% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.405.197 | 2.656.359 | 2,28% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.780.697 | 2.522.163 | 2,16% | Aktien |
| Ikarian Capital, LLC | $11.362.110 | 2.433.000 | 2,09% | Aktien |
| STATE STREET CORP | $9.879.950 | 2.115.621 | 1,81% | Aktien |
| Candriam S.C.A. | $8.383.622 | 1.796.937 | 1,54% | Aktien |
| VANGUARD GROUP INC | $8.365.446 | 4.379.815 | 1,54% | Aktien |
| D. E. Shaw & Co., Inc. | $8.130.419 | 1.740.989 | 1,49% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.089.421 | 1.732.210 | 1,49% | Aktien |
| WASATCH ADVISORS LP | $7.789.431 | 2.961.761 | 1,43% | Aktien |
| Patient Square Capital LP | $7.513.166 | 1.608.815 | 1,38% | Aktien |
| HighVista Strategies LLC | $6.295.800 | 1.348.136 | 1,16% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.556.497 | 1.189.828 | 1,02% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $5.546.166 | 1.188.507 | 1,02% | Aktien |
| NORTHERN TRUST CORP | $5.419.754 | 1.160.547 | 0,99% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $4.686.051 | 1.003.437 | 0,86% | Aktien |
| FMR LLC | $4.175.231 | 894.054 | 0,77% | Aktien |
| UBS Group AG | $3.871.289 | 828.970 | 0,71% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.647.550 | 781.060 | 0,67% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.438.666 | 736.331 | 0,63% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.176.039 | 680.094 | 0,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.844.712 | 609.146 | 0,52% | Aktien |
| ExodusPoint Capital Management, LP | $2.709.511 | 580.195 | 0,50% | Aktien |
| Velan Capital Investment Management LP | $2.661.900 | 570.000 | 0,49% | Aktien |
| STEMPOINT CAPITAL LP | $2.445.436 | 523.648 | 0,45% | Aktien |
| Rockefeller Capital Management L.P. | $2.315.465 | 495.817 | 0,43% | Aktien |
| Nuveen, LLC | $2.260.326 | 484.010 | 0,41% | Aktien |
| WELLS FARGO & COMPANY/MN | $2.114.113 | 452.701 | 0,39% | Aktien |
| TWO SIGMA ADVISERS, LP | $2.040.262 | 1.068.200 | 0,37% | Aktien |
| Man Group plc | $1.908.386 | 408.648 | 0,35% | Aktien |
| Squadron Capital Management LLC | $1.868.000 | 400.000 | 0,34% | Kaufoption |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1.796.857 | 384.766 | 0,33% | Aktien |
| Seven Fleet Capital Management LP | $1.780.059 | 381.169 | 0,33% | Aktien |
| Qube Research & Technologies Ltd | $1.730.487 | 370.554 | 0,32% | Aktien |
| Atom Investors LP | $1.701.519 | 364.351 | 0,31% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.564.819 | 335.079 | 0,29% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.517.750 | 325.000 | 0,28% | Aktien |
| JANE STREET GROUP, LLC | $1.413.843 | 302.750 | 0,26% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Cobro Ventures Opportunity Fund, L.P., Cobro Opportunity Fund GP, LLC, Marc Cohen, Alain Cohen, Todd Kaloudis ×2 Einreichungen | 15. Juni 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 27 Insider · 13 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrew Hirsch | President & CEO | 15. Februar 2026 F | 1.074.934 | 0 | 0 | $0 |
| Kendra Adams | Chief Financial Officer | 18. September 2026 F | 382.323 | 0 | 0 | $0 |
| Lauren White | Chief Financial Officer | 30. August 2023 M | 32.686 | 0 | 0 | $0 |
| William Mckee | Chief Financial Officer | 6. Oktober 2020 P | 5.263 | 0 | 0 | $0 |
| Leonard Reyno | Chief Medical Officer | 10. Juli 2026 F | 372.406 | 0 | 1 | $-22.200 |
| Paige Mahaney | Chief Scientific Officer | 14. Februar 2026 F | 336.910 | 0 | 0 | $0 |
| Mark Mossler | Chief Accounting Officer | 14. Februar 2026 F | 71.916 | 0 | 0 | $0 |
| Scott N Boyle | Chief Business Officer | 14. Februar 2026 F | 298.801 | 0 | 0 | $0 |
| Kelly Schick | Chief People Officer | 14. Februar 2026 F | 299.881 | 0 | 0 | $0 |
| Jolie Siegel | Chief Legal Officer | 14. Februar 2025 A | 107.939 | 0 | 0 | $0 |
| Stewart Fisher | Chief Scientific Officer | 16. September 2024 M | 130.710 | 0 | 0 | $0 |
| Adam Crystal | Chief Medical Officer | 30. Januar 2023 M | 20.097 | 0 | 0 | $0 |
| Laura Jean Wahlberg | VP of Finance Corp Controller | 11. Februar 2021 A | · | 0 | 0 | $0 |
| Kenneth Carl Anderson | Direktor | 1. Oktober 2026 A | 75.612 | 0 | 0 | $0 |
| Donna Roy Grogan | Direktor | 1. Oktober 2026 A | 79.471 | 0 | 0 | $0 |
| Stephen Fawell | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Laura Bessen | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Utpal Koppikar | Direktor | 24. Juni 2026 A | 5.667 | 0 | 0 | $0 |
| Ronald Harold Wilfred Cooper | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Owen Hughes | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Steven L. Hoerter | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Malcolm Salter | Direktor | 20. Juni 2024 A | 11.380 | 0 | 0 | $0 |
| Bruce Downey | Direktor | 20. Juni 2024 A | 489.542 | 0 | 0 | $0 |
| Glenn Dubin | Direktor | 1. April 2024 A | 22.075 | 0 | 0 | $0 |
| Marc A Cohen | Direktor | 22. Juni 2022 A | 1.118 | 0 | 0 | $0 |
| Alain J Cohen | Direktor | 4. April 2022 A | 928 | 0 | 0 | $0 |
| Elena Prokupets | Direktor | 27. September 2021 S | 503.126 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 20 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,44% | 32.308 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,08% | 342.369 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 88.122 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,03% | 845.464 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 232.512 SH | 2. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 8.690 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 2.614.567 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 48.213 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 583.446 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 235.215 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 3.906 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 14.611 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 8.504 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 115.180 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.202 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 21.036 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.046.993 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.264.924 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.526 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 926.223 SH | 11. September 2026 | Täglich |
CCCC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$11.00
+272,9%
4 30,8%
Starker Kauf
8 61,5%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-09-30Mittelwert-Ziel $13.33 +352,0%
← Unter allen Zielen
Aktueller Preis $2.95
Tief$7.00
Mittelwert$13.33
Hoch$30.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| EIKN | · | · | · | · | · | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026